GLP-1: tra miracolo e rischio. La verità sui super-farmaci dimagranti

from Dottor Podcast · host Panorama

Dai successi contro obesità, diabete e malattie cardiovascolari agli effetti collaterali gravi: i farmaci a base di semaglutide e tirzepatide dividono la medicina e aprono nuove sfide in corsia.

Episode metadata supplied by the publisher feed · Published Oct 27, 2025

Embed this episode

Attribution link and audio player

Ready to play

GLP-1: tra miracolo e rischio. La verità sui super-farmaci dimagranti

0:00 7:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dottor Podcast?

This episode is 7 minutes long.

When was this Dottor Podcast episode published?

This episode was published on October 27, 2025.

Can I download this Dottor Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!